A.W. Karchmer Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Clinical Microbiology and Infection

Gram-positive infections: lessons learnt and novel solutions

Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus.

Clinical Microbiology and Infection

Clinical Microbiology and Infection

G. Cornaglia, A. Lönnroth, M. Struelens

M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans

Approach to diagnosis of infective endocarditis

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Clinical impact of antibiotic-resistant Gram-positive pathogens

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

J.-P. Stahl Clinical Microbiology and Infection

Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? M. Paul, N. Zemer-Wassercug, O.

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

Appropriate vs. inappropriate antimicrobial therapy

Treatment of staphylococcal infections with cyclic lipopeptides

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

Targeted antibiotic management of ventilator-associated pneumonia

G. Sakoulas Clinical Microbiology and Infection

P.C. Appelbaum Clinical Microbiology and Infection

Do we need new antibiotics?

L.R. Peterson Clinical Microbiology and Infection

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia A. Budimir, R.H. Deurenberg, Z. Bošnjak,

Bacterial resistance—the clinical challenge

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia M. Bassetti, E.M. Trecarichi, A. Mesini,

Strategies for managing today's infections

Panton–Valentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain

Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.

Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections

Levofloxacin in the treatment of ventilator-associated pneumonia

M. Aires-de-Sousa Clinical Microbiology and Infection

Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals E.E. Udo, N. Al-Sweih, B.

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated.

Antibacterial drug discovery in the 21st century

Can β-lactams be re-engineered to beat MRSA?

P.M. Hawkey Clinical Microbiology and Infection

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan

Reducing antibiotic use in influenza: challenges and rewards

Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study J. Smit, L.E. López-Cortés,

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

P. Kaltsas, S. Want, J. Cohen Clinical Microbiology and Infection

Clinical Microbiology and Infection

J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult

Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin.

Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting A. Kronenberg, S. Koenig, S. Droz,

Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.

E. Tacconelli Clinical Microbiology and Infection

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T

A. Manzur, F. Gudiol Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

Test results: characterising the antimicrobial activity of daptomycin

G.C. Schito Clinical Microbiology and Infection

Impact of source of infection and vancomycin AUC0–24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus.

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Presentation transcript:

From theory to practice: resistance in Staphylococcus aureus and new treatments A.W. Karchmer Clinical Microbiology and Infection Volume 12, Pages 15-21 (January 2006) DOI: 10.1111/j.1469-0691.2006.01626.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Failure of vancomycin vs. nafcillin in the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia [31]. Reproduced with permission from Lippincott Williams & Wilkins. Clinical Microbiology and Infection 2006 12, 15-21DOI: (10.1111/j.1469-0691.2006.01626.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Daptomycin treatment outcome in 344 patients with complicated skin and soft tissue infections (R. Owens et al. ICAAC 2005) Clinical Microbiology and Infection 2006 12, 15-21DOI: (10.1111/j.1469-0691.2006.01626.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Treatment success rates for daptomycin and comparator antibiotics in patients with Staphylococcus aureus bacteraemia and known or suspected infective endocarditis [43]. Clinical Microbiology and Infection 2006 12, 15-21DOI: (10.1111/j.1469-0691.2006.01626.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions